This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Quretech Bio Ab. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Andrew Gerard Cairns: Innovator in Antibacterial Agents
Introduction
Andrew Gerard Cairns is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. His innovative work has led to the creation of novel compounds that hold promise in treating bacterial infections.
Latest Patents
Cairns holds a patent for "2,3-dihydro-thiazolo[3,2-A]pyridin-5-one derivatives, intermediates thereof, and their use as antibacterial agents." This patent discloses certain novel substituted ring-fused thiazolino 2-pyridines of Formula I. It details processes for preparing these compounds, their therapeutic use in treating bacterial infections, and pharmaceutical compositions containing them.
Career Highlights
Cairns is currently associated with Quretech Bio AB, where he continues to advance his research in antibacterial agents. His work is characterized by a commitment to innovation and the development of effective treatments for bacterial infections.
Collaborations
Cairns collaborates with esteemed colleagues, including James Arthur Dudley Good and Anna Martina Kulén. These partnerships enhance the research and development efforts at Quretech Bio AB.
Conclusion
Andrew Gerard Cairns is a prominent figure in the field of antibacterial research, with a focus on innovative compounds that can combat bacterial infections. His contributions are paving the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile